Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
31.37
-1.06 (-3.27%)
Nov 20, 2026, 4:00 PM EST - Market closed
Maze Therapeutics Revenue
Maze Therapeutics had revenue of $20.00M in the twelve months ending September 30, 2026. That makes Maze Therapeutics the 33,922nd largest company in the world by revenue and 4,445th in the United States.
Revenue (ttm)
$20.00M
Revenue Growth
n/a
P/S Ratio
85.77
Revenue / Employee
$141,844
Employees
141
Market Cap
1.72B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 167.50M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
MAZE News
- 4 days ago - Maze Therapeutics Transcript: Jefferies Global Healthcare Conference - Transcripts
- 11 days ago - Maze Therapeutics price target lowered to $51 from $53 at JPMorgan - TheFly
- 11 days ago - Maze Therapeutics Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 11 days ago - Maze Therapeutics reports Q3 EPS (79c), consensus (75c) - TheFly
- 11 days ago - Maze Therapeutics completes enrollment in Phase 2 HORIZON trial - TheFly
- 12 days ago - Maze Therapeutics Reports Third Quarter 2026 Financial Results and Recent Highlights - GlobeNewsWire
- 12 days ago - Maze Therapeutics Earnings release: Q3 2026 - Filings
- 12 days ago - Maze Therapeutics Quarterly report: Q3 2026 - Filings